Wave Life Sciences Stock Analysis

WVE Stock  USD 6.04  0.38  6.71%   
Wave Life Sciences is fairly valued with Real Value of 6.17 and Target Price of 7.69. The main objective of Wave Life stock analysis is to determine its intrinsic value, which is an estimate of what Wave Life Sciences is worth, separate from its market price. There are two main types of Wave Life's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Wave Life's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Wave Life's stock to identify patterns and trends that may indicate its future price movements.
The Wave Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Wave Life is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Wave Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Wave Life's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Wave Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.54. Wave Life Sciences had not issued any dividends in recent years. Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. For more information please call MBA MD at 65 6236 3388 or visit https://www.wavelifesciences.com.

Wave Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Wave Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Wave Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Wave Life Sciences had very high historical volatility over the last 90 days
The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M).
Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Wave Life Sciences has a poor financial position based on the latest SEC disclosures
Roughly 75.0% of the company outstanding shares are owned by institutional investors
Latest headline from simplywall.st: Estimating The Fair Value Of Novogene Co., Ltd.

Wave Life Sciences Upcoming and Recent Events

Earnings reports are used by Wave Life to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Wave Life previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Wave Largest EPS Surprises

Earnings surprises can significantly impact Wave Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-22
2022-12-31-0.41-0.47-0.0614 
2022-05-12
2022-03-31-0.56-0.62-0.0610 
2024-03-06
2023-12-31-0.23-0.150.0834 
View All Earnings Estimates

Wave Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Wave Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Wave Life Sciences backward and forwards among themselves. Wave Life's institutional investor refers to the entity that pools money to purchase Wave Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2023-12-31
1.5 M
Maven Securities Ltd2023-12-31
1.5 M
Woodline Partners Lp2023-12-31
1.4 M
Vanguard Group Inc2023-12-31
1.3 M
State Street Corporation2023-12-31
1.3 M
Fmr Inc2023-12-31
1.2 M
Laurion Capital Management Lp2023-09-30
871.5 K
Goldman Sachs Group Inc2023-12-31
782.3 K
Junked Platinum Investment Management Ltd2023-12-31
655.3 K
Ra Capital Management, Llc2023-12-31
18.2 M
Maverick Capital Ltd2023-12-31
8.4 M
Note, although Wave Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Wave Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 736.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Wave Life's market, we take the total number of its shares issued and multiply it by Wave Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Wave Profitablity

Wave Life's profitability indicators refer to fundamental financial ratios that showcase Wave Life's ability to generate income relative to its revenue or operating costs. If, let's say, Wave Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Wave Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Wave Life's profitability requires more research than a typical breakdown of Wave Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.51) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.64) %, which entails that for every $100 of revenue, it lost $0.64.
Last ReportedProjected for 2024
Return On Capital Employed(0.77)(0.81)
Return On Assets(0.21)(0.22)
Return On Equity(1.21)(1.27)

Management Efficiency

Wave Life Sciences has Return on Asset of (0.2017) % which means that on every $100 spent on assets, it lost $0.2017. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (11.1817) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of March 28, 2024, Return On Capital Employed is expected to decline to -0.81. In addition to that, Return On Assets is expected to decline to -0.22. At present, Wave Life's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.33, whereas Other Assets are forecasted to decline to about 4.1 M.
Last ReportedProjected for 2024
Price Book Value Ratio 11.28  16.29 
Enterprise Value Multiple(6.25)(6.56)
Price Fair Value 11.28  16.29 
The analysis of Wave Life's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Wave Life's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Wave Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
(1.17)

Technical Drivers

As of the 28th of March, Wave Life maintains the Market Risk Adjusted Performance of (3.97), downside deviation of 4.61, and Mean Deviation of 3.75. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sciences, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Wave Life Sciences, which can be compared to its rivals. Please check out Wave Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Wave Life Sciences is priced fairly, providing market reflects its latest price of 6.04 per share. Given that Wave Life Sciences has jensen alpha of 0.4056, we strongly advise you to confirm Wave Life Sciences's prevalent market performance to make sure the company can sustain itself at a future point.

Wave Life Sciences Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Wave Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Wave Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Wave Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Wave Life Predictive Daily Indicators

Wave Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Wave Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Wave Life Corporate Filings

8K
6th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
12th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
7th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
6th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
30th of January 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
17th of January 2024
Other Reports
ViewVerify

Wave Life Forecast Models

Wave Life's time-series forecasting models are one of many Wave Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Wave Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Wave Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Wave Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Wave shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Wave Life. By using and applying Wave Stock analysis, traders can create a robust methodology for identifying Wave entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(0.51)(0.54)
Operating Profit Margin(0.60)(0.63)
Net Loss(0.51)(0.53)
Gross Profit Margin 0.92  0.96 

Current Wave Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Wave analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Wave analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.69Strong Buy6Odds
Wave Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Wave analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Wave stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Wave Life Sciences, talking to its executives and customers, or listening to Wave conference calls.
Wave Analyst Advice Details

Wave Stock Analysis Indicators

Wave Life Sciences stock analysis indicators help investors evaluate how Wave Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Wave Life shares will generate the highest return on investment. By understating and applying Wave Life stock analysis, traders can identify Wave Life position entry and exit signals to maximize returns.
Begin Period Cash Flow88.5 M
Common Stock Shares Outstanding106.1 M
Total Stockholder Equity47.5 M
Tax Provision-677 K
Property Plant And Equipment Net35.7 M
Cash And Short Term Investments200.4 M
Cash200.4 M
Accounts Payable12.8 M
Net Debt-168.2 M
50 Day M A4.9344
Total Current Liabilities186.4 M
Other Operating Expenses181.3 M
Non Current Assets Total39.6 M
Non Currrent Assets Other156 K
Stock Based Compensation9.8 M
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Wave Stock analysis

When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Wave Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
1.068
Quarterly Revenue Growth
22.451
Return On Assets
(0.20)
Return On Equity
(11.18)
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.